| Factor Information | |
|---|---|
| Data ID | 3867 |
| Factor | prevalence of persistent left superior vena cava (PLSVC) |
| Description | Among 3671 patients aged 0-15 years with congenital heart disease diagnosed by cardiac catheterization and/or autopsy, 49 or 1.3% had a persistent left superior vena cava (PLSVC). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the prevalence of PLSVC with CHD. |
| Conclusion | Among 3671 patients aged 0-15 years with CHD diagnosed by cardiac catheterization and/or autopsy, 49 or 1.3% had a persistent left superior vena cava (PLSVC). The potential importance of PLSVC for the surgical risk during operation for congenital heart disease and for instability of the cardiac rhythm is emphasized. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 718 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/PDA/ASD/CoA/TOF/TGA/PS/AVC/AS/TAS/TA/TAPVC/PA/EA/other/ioslated PLSVC |
| Reference | |
|---|---|
| PMID | 7368902 |
| Year | 1980 |
| Title | Persistent left superior vena cava. Incidence, associated congenital heart defects and frontal plane P-wave axis in a paediatric population with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | neonate/children/adolecents | |
| Source | observational study | |
| Region | Aarhus, Denrnork | |
| Method | diagnosed by cardiaccatheterizationand/orautopsy | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | patients(Treatment) | N/A(Control) |
| Number | 49 | N/A |
| Age | 0~15 years | N/A |
| Gender (Male: Female) | 20:29 | N/A |
| Marker Level | 0.013 | N/A |
